| Peptide Vaccinations Plus GM-CT-01 in Melanoma (NCT01723813) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2012-04-01 |
| A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors (NCT01562275) | Genentech, Inc. | 2012-04-01 |
| Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy (NCT01692704) | University of Zurich | 2012-04-01 |
| Safety and Efficacy Study of Cells Sheet-Autologous Chondrocyte Implantation to Treat Articular Cartilage Defects (NCT01694823) | Yan Jin | 2012-04-01 |
| Assessment of Hand-grip in the Prevention of Postural Orthostatic Hypotension (NCT01521221) | Tel-Aviv Sourasky Medical Center | 2012-04-01 |
| Safety Study of FluMist With and Without Ampligen (NCT01591473) | AIM ImmunoTech Inc. | 2012-04-01 |
| A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects (NCT01581242) | Bukwang Pharmaceutical | 2012-04-01 |
| Optimizing the Treatment of Toenail Onychomycosis Using a New Transdermal Patch Combined With Terbinafine/Ketoconazole (NCT01615913) | Taiwan Biotech Co., Ltd. | 2012-04-01 |
| Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients (NCT02058680) | OncBioMune Pharmaceuticals | 2012-04-01 |
| Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb (NCT01560884) | Spectrum Pharmaceuticals, Inc | 2012-04-01 |
| Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 (NCT01585181) | Bavarian Nordic | 2012-04-01 |
| A Study of LY110140 in Healthy Japanese Male Participants (NCT01569126) | Eli Lilly and Company | 2012-04-01 |
| IPF Drug Deposition Study (NCT01457261) | Royal Brompton & Harefield NHS Foundation Trust | 2012-04-01 |
| Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma (NCT01577953) | Sterna Biologicals GmbH & Co. KG | 2012-04-01 |
| ADIPOA - Clinical Study (NCT01585857) | University Hospital, Montpellier | 2012-04-01 |
| Multiple Transplantation of Bone Marrow Derived CD133 Cell in Cerebral Palsy (NCT01763255) | Royan Institute | 2012-04-01 |
| Safety Study of Ch-mAb7F9 for Methamphetamine Abuse (NCT01603147) | InterveXion Therapeutics, LLC | 2012-04-01 |
| Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes (NCT01581658) | Boehringer Ingelheim | 2012-04-01 |
| A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B (NCT01590641) | Gilead Sciences | 2012-04-01 |
| CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant (NCT01475058) | Fred Hutchinson Cancer Center | 2012-04-01 |
| A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP) (NCT01589029) | PD Dr. med. Stephan Michels | 2012-04-01 |
| A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers (NCT01592890) | Hoffmann-La Roche | 2012-04-01 |
| Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant (NCT01390311) | Washington University School of Medicine | 2012-04-01 |
| A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma (NCT01551628) | Bio-Cancer Treatment International Limited | 2012-04-01 |
| Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning? (NCT02040350) | Sheri Kashmir Institute of Medical Sciences | 2012-04-01 |
| Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers (NCT01383096) | Medicines for Malaria Venture | 2012-04-01 |
| A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211 (NCT01568411) | Glycyx Therapeutics | 2012-04-01 |
| Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide (NCT01200004) | M.D. Anderson Cancer Center | 2012-04-01 |
| Cumulative Irritation Test of PAC-14028 in Healthy Volunteers (NCT01638117) | Amorepacific Corporation | 2012-04-01 |
| Intra-arterial Chemotherapy for Spinal Metastases (NCT01637766) | Weill Medical College of Cornell University | 2012-04-01 |
| Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC (NCT01562210) | The Netherlands Cancer Institute | 2012-04-01 |
| A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates (NCT01623557) | University of Oxford | 2012-04-01 |
| Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome (NCT01603745) | Catholic University of the Sacred Heart | 2012-04-01 |
| Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G) (NCT01588717) | Thomas Jefferson University | 2012-04-01 |
| FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma (NCT01413022) | Washington University School of Medicine | 2012-04-01 |
| Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension (NCT01858831) | GlaxoSmithKline | 2012-04-01 |
| Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets (NCT01581931) | Boehringer Ingelheim | 2012-04-01 |
| Maintenance Lenalidomide in Lymphoma (NCT01575860) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
| Ultrasound Assisted Distal Radius Fracture Reduction (NCT01561573) | University of British Columbia | 2012-04-01 |
| A Study of LY3016859 in Healthy Volunteers (NCT01545583) | Eli Lilly and Company | 2012-04-01 |
| A Study of LY2784544 in Healthy Male Subjects (NCT01577355) | Eli Lilly and Company | 2012-04-01 |
| A Study to Explore the Pharmacokinetics of Rilpivirine With Rifabutin in Healthy Participants (NCT01615614) | Janssen R&D Ireland | 2012-04-01 |
| A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers (NCT01830660) | Jiangsu HengRui Medicine Co., Ltd. | 2012-04-01 |
| A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy (NCT01713387) | Kansai Hepatobiliary Oncology Group | 2012-04-01 |
| Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer (NCT01975454) | Shanghai University of Traditional Chinese Medicine | 2012-04-01 |
| A Cognitive Behavioral Therapy-Based Text Messaging Intervention for Methamphetamine Dependence (NCT01577797) | New Leaf Treatment Center | 2012-04-01 |
| Chewing Gum Use to Reduce Post-operative Ileus in Pediatric Patients (NCT01583452) | Instituto Tecnologico y de Estudios Superiores de Monterey | 2012-04-01 |
| Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine (NCT01507779) | PATH | 2012-04-01 |
| Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition (NCT01589562) | Daewon Pharmaceutical Co., Ltd. | 2012-04-01 |
| Deep Brain Stimulation and Capsulotomy for the Treatment of Refractory Anorexia Nervosa (NCT01678014) | Ruijin Hospital | 2012-04-01 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX (NCT01587391) | Boehringer Ingelheim | 2012-04-01 |
| Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone (NCT01597986) | Astellas Pharma Global Development, Inc. | 2012-04-01 |
| A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers (NCT01579526) | Avalo Therapeutics, Inc. | 2012-04-01 |
| Low Tidal Volume and EVLWI During OLV (NCT01762709) | Imam Abdulrahman Bin Faisal University | 2012-04-01 |
| Multimodal Imaging Assessment of the Inflammatory Atheromatous Plaque (NCT01608516) | University of Lausanne Hospitals | 2012-04-01 |
| Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer (NCT01584284) | Genelux Corporation | 2012-04-01 |
| Molecular Regulation of Muscle Glucose Metabolism (NCT01581736) | Mayo Clinic | 2012-04-01 |
| A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on Methotrexate (NCT02171143) | Astellas Pharma Global Development, Inc. | 2012-04-01 |
| Effect of Nutriose Supplementation on Satiety, Weight Loss and Adiposity in Overweight Subjects (NCT01897662) | Nealth Sarl | 2012-04-01 |
| Regional Lung Imaging Using Hyperpolarized Xenon Gas (NCT02112929) | Oxford University Hospitals NHS Trust | 2012-04-01 |
| Phase 1 Study of Preoperative Gemcitabine Plus CP-870, 893 Followed by Addition of CP-870,893 to Standard -Of-care Adjuvant Chemoradiation for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma (NCT01456585) | Abramson Cancer Center at Penn Medicine | 2012-04-01 |
| A Study of LY2979165 and LY2140023 in Healthy Volunteers (NCT01524237) | Eli Lilly and Company | 2012-04-01 |
| Study to Determine the Safety and Feasibility of Utilizing the CD Leycom Pressure/Conductance Catheter to Determine Optimal LV Pacing Site (NCT01586884) | Lancaster General Hospital | 2012-04-01 |
| A Study To Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment (NCT01571388) | Pfizer | 2012-04-01 |
| Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment (NCT01594957) | Novartis Pharmaceuticals | 2012-04-01 |
| A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes (NCT01590836) | Novo Nordisk A/S | 2012-04-01 |
| Mindfulness Meditation Format Pilot Study (NCT01581983) | Oregon Health and Science University | 2012-04-01 |
| A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients With Myelodysplastic Syndromes (NCT01571648) | Celgene | 2012-04-01 |
| Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma (NCT01568294) | Celgene | 2012-04-01 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 187004 CL (NCT01587417) | Boehringer Ingelheim | 2012-04-01 |
| Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease (NCT01560585) | University Hospitals Cleveland Medical Center | 2012-04-01 |
| Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients (NCT01525212) | Bristol-Myers Squibb | 2012-04-01 |
| Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer (NCT01548144) | M.D. Anderson Cancer Center | 2012-04-01 |
| A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route (NCT01576523) | CSL Behring | 2012-04-01 |
| Intravitreal Injection of MSCs in Retinitis Pigmentosa (NCT01531348) | Mahidol University | 2012-04-01 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002) (NCT01554189) | Merck Sharp & Dohme LLC | 2012-04-01 |
| Drug-drug Interaction of BI 201335 and Microgynon (NCT01570244) | Boehringer Ingelheim | 2012-04-01 |
| A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects (NCT01806324) | HanAll BioPharma Co., Ltd. | 2012-04-01 |
| WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study (NCT01621724) | Cell Medica Ltd | 2012-04-01 |
| Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI (NCT01605344) | UNC Lineberger Comprehensive Cancer Center | 2012-04-01 |
| Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors (NCT01548924) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2012-04-01 |
| Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases (NCT01538667) | Bayer | 2012-04-01 |
| Pharmacokinetics And Relative Bioavailability Study Of Oxycodone (NCT01552850) | Pain Therapeutics | 2012-04-01 |
| Safety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the Knee (NCT01645709) | Calosyn Pharma, Inc. | 2012-04-01 |
| Creating LASIK Flaps With the LenSx Femtosecond Laser (NCT01556893) | Alcon LenSx, Inc. | 2012-04-01 |
| Drug Interaction Study of Isavuconazole and Methadone (NCT01582425) | Astellas Pharma Global Development, Inc. | 2012-04-01 |
| Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer (NCT01494012) | Stanford University | 2012-04-01 |
| Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma (NCT00903461) | University of Pittsburgh | 2012-04-01 |
| Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer (NCT01580696) | COL George Peoples, MD, FACS | 2012-04-01 |
| A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects (NCT01581463) | Ipe, LLC | 2012-04-01 |
| Yoga for Pain and Opioid Dependence (NCT01590251) | Yale University | 2012-04-01 |
| A 2-part Study to Assess Local Tolerability, Safety and Pharmacokinetics of Ceftaroline in Healthy Subjects (NCT01577589) | Pfizer | 2012-04-01 |
| Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia (NCT02034227) | Spirogen | 2012-04-01 |
| Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes (NCT01576328) | Mesoblast, Ltd. | 2012-04-01 |
| A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies (NCT00820768) | Celgene | 2012-04-01 |
| Influence of a Delivery System on the Efficacy of a Probiotic Intervention (NCT01399996) | Penn State University | 2012-04-01 |
| A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions (NCT01619527) | Janssen R&D Ireland | 2012-04-01 |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors (NCT01966913) | Assistance Publique - Hôpitaux de Paris | 2012-04-01 |
| Rituximab in IgG4-RD: A Phase 1-2 Trial (NCT01584388) | Massachusetts General Hospital | 2012-04-01 |
| Safety Tolerability and Pharmacokinetics of ALD403 (NCT01579383) | Alder Biopharmaceuticals, Inc. | 2012-04-01 |